This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Ligand Pharmaceuticals Inc (LGND)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 160.20M 11.64M 12.38M 7.04M
Receivables 13.64M 6.55M 8.94M 12.31M
Inventories 269.00K 1.39M 1.70M 1.30M
Other Current Assets 3.08M 959.00K 0.00 1.34M
Total Current Assets 185.16M 24.88M 23.82M 32.23M
Property, Plant & Equipment, Gross 3.13M 4.74M 5.67M 5.23M
Accumulated Depreciation & Depletion 2.64M 3.87M 4.88M 4.77M
Property, Plant & Equipment, Net 486.00K 867.00K 788.00K 455.00K
Intangibles 55.29M 57.67M 55.91M 57.44M
Other Non-Current Assets 4.86M 9.06M 11.49M 17.33M
Total Non-Current Assets 72.87M 79.83M 80.44M 90.12M
Liabilities & Shareholder Equity
Total Assets 258.03M 104.71M 104.26M 122.35M
Accounts Payable 7.70M 3.95M 5.85M 11.06M
Short Term Debt 2.36M 0.00 0.00 10.00M
Other Current Liabilities 7.12M 8.85M 7.72M 13.08M
Total Current Liabilities 22.78M 28.94M 35.44M 43.64M
Long Term Debt 195.91M 0.00 13.44M 20.29M
Deferred Income Taxes 2.79M 1.10M 334.00K 2.52M
Other Non-Current Liabilities 11.21M 25.06M 28.56M 47.25M
Minority Interest -1.13M 0.00 0.00 0.00
Total Non-Current Liabilities 208.93M 26.16M 42.34M 70.06M
Total Liabilities 231.71M 55.10M 77.78M 113.70M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 26.32M 49.61M 26.48M 8.65M
Common Par 20.00K 21.00K 21.00K 21.00K
Additional Paid In Capital 680.66M 718.02M 751.50M 732.68M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -659.32M -671.34M -682.76M -681.77M
Treasury Stock 0.00 0.00 -42.28M -42.28M
Other Equity Adjustments 4.95M 2.91M 0.00 0.00
Total Capitalization 222.23M 49.61M 39.93M 28.93M
Total Equity 26.32M 49.61M 26.48M 8.65M
Total Liabilities & Stock Equity 258.03M 104.71M 104.26M 122.35M
Total Common Shares Outstanding 19.58M 20.47M 20.16M 19.56M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 1.12M 1.12M
Basic Weighted Shares Outstanding 20.42M 20.31M 19.85M 19.66M
Diluted Weighted Shares Outstanding 21.43M 20.75M 19.85M 19.71M
Number of Employees 19 20 21 21
Number of Part-Time Employees 0 0 0 0

LGND Ligand Pharmaceuticals Inc

Analysts Ratings for LGND

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 3 4 5
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

LGND Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs